BIO 2025

Fareva Pilots New GMP Unit at Pau Site

Opens a new GMP Pilot Unit to produce liquid and lyophilized injectable forms.

BIO 2025

Mabion Launches €500,000 Oncology Services Contest

An independent jury of experts will evaluate entries based on scientific merit, feasibility, and potential patient impact.

BIO 2025

LOTTE Biologics, Ottimo Pharma Sign Antibody Manufacturing Contract 

LOTTE will produce antibody drug substance for Ottimo Pharma's Jankistomig at its Syracuse, NY Bio Campus.

BIO 2025

Enzene Expands Biomanufacturing Operations at New Jersey Site

Plans include 26,000 square feet of drug substance manufacturing suites, labs, storage, dispensing, and warehousing.

BIO 2025

Aragen Biomanufacturing Site Completes Qualification with GMP Batches  

Demonstrates the productivity of its intensified fed batch cell culture manufacturing platform to deliver titers >25 g/L.